DailyWealth Investment Newsletter  

About DailyWealth Premium Content DailyWealth Archive
DailyWealth Investment Newsletter DailyWealth Contributors DailyWealth Resources DailyWealth Market Window
 
DailyWealth Print Edition Print Edition | Sponsored Link:
True Wealth Login

My Secret Investment is Getting Out...
By Dr. Steve Sjuggerud
December 4, 2007

Today, we'll start with a little game... A little investment trivia...

Simply match each asset with its return on $10k invested over the last 20 years (through 2006):

A.
Stocks
 
1.
$15,000
B.
Bonds
 
2.
$16,000
C.
Timberland
 
3.
$31,000
D.
Gold
 
4.
$83,000
E.
Cash
 
5.
$159,000

Think about it...

Two of these should be easy... cash earning interest and gold are at the bottom of the list ($15,000 and $16,000 returns over 20 years, respectively).

Now let's think about the other three...

It should be an easy guess to say that stocks have beaten bonds. But where does timber fit in?

Is timber a lowly commodity and a boring business? Let's see, if timber returned 7.35% a year, then the total return over 20 years would have been the $31,000 number above. Does that sound about right for trees?

Actually, timber is at the top of the list.

According to a recent S&P report, a $10,000 investment in timberland returned $159,000 over the last 20 years. That's nearly twice the return of the stock market.

I've been writing about timberland to my readers for years. We bought shares of timber REIT Plum Creek Timber in my newsletter True Wealth, for example, at around $35 a share. Today, it's closer to $46. And we've earned about $5 in dividends over that time, for an excellent total return.

In my letter Sjuggerud Confidential, we bought shares of timberland company Pope Resources for $31 in January 2005. Shares are around $43 now. Once again, we collected handsome dividends along the way, for a nice, safe, big return.

We've only sold one timberland recommendation in True Wealth – and that was Rayonier. Heck, you'd have sold it too! We just about doubled our money in no time on that one – in trees! (One of our Stansberry Research Advisory Board members is a timberland valuation expert, and he told our readers at our conference in Mexico last week that he'll be a buyer of Rayonier shares again soon.)

During my timberland research, I've logged tens of thousands of miles on airplanes with an expert. We've looked at timber from the Pacific Northwest to the southeastern U.S. And we've even flown all over Argentina sizing up the timberland opportunities.

The chart on this page tells the story... Not only has timberland itself been a great holding over the last 20 years, the three timberland stocks I've mentioned have soared as well.

S&P just launched a new 25-stock Timber and Forestry Index. Backtested to 2003, the returns have been an astonishing 17.2% a year. This includes some tough times, as demand for lumber and building products has shrunk in recent years. What's so great about timberland as an investment?

The list is ridiculously long...

High returns. We've already covered that.
It's a sustainable asset that will keep giving returns for infinity.
No correlation to stocks.
Less volatility than the stock market.
"Stumpage" (all the wood from the tree) prices have beaten inflation by about 3% a year for nearly a century.
Unlike businesses, trees easily compound their growth at about 6%-8% per year.
Supply and demand... Fewer trees and more people could lead to higher prices.
Valuable real estate. Eventually, some timberland acres turn into expensive neighborhoods.
New demand for timberland. Big institutional investors are getting into timberland as an asset class for the first time in history.

I could go on. The return numbers speak for themselves – higher returns than stocks with lower volatility. And they have no correlation to stocks. It's just about the investment Holy Grail.

Related Articles

Why the #1 Investment of the Last 45 Years is Still a Buy

Timber Stocks: Up 40% and Still a Good Deal

I've found several more timberland investments that I plan to research (and hopefully recommend) in the coming year. If you haven't already taken a position in timber, it's not too late. I believe the next years will give you returns similar to the past 20.

Good investing,

Steve

Editor's note: Steve Sjuggerud is a regular contributor to DailyWealth, a free investment newsletter focused on the world's best contrarian opportunities. We write with a simple belief in mind: You don't have to take big risks to make big money with your investments.

Sign up today to read more investment ideas from Steve Sjuggerud.

Email a Friend

Delicious
Reddit

Digg

RSS

TAKE THE CHRISTMAS PARTY BIOTECH CHALLENGE!

Back in September we asked DailyWealth readers if they were familiar with the following stocks: Vertex Pharmaceuticals... Amylin Pharmaceuticals... Biogen Idec. We guess 99.9% of readers weren't.

It's this kind of indifference that's keeping today's bull market in biotech stocks a secret. In September's column, we pointed out how, after getting crushed in biotech seven years ago, investors can't stand the thought of buying something with "genics" or "ceuticals" in its name.

Here's how you can test this sentiment yourself: At this year's Christmas party, tell a few folks that you're thinking about buying biotech shares. We'll guess you'll hear a groan, followed by, "I lost a fortune in those things seven years ago... and I'll never touch 'em again."

As long-time DailyWealth readers know, it's this kind of apathy and disgust toward a sector that signals a bear market bottom and great values. It's a contrarian's "buy" signal. And as our chart of the S&P Biotech ETF shows, biotech's bear market is not only finished, it has switched to a bull market in full.

S&P Biotech Index ETF

– Brian Hunt

Profits for the Standard & Poor's 500 companies fell almost 25 percent on a per-share basis in the third quarter, the biggest year-over-year decline in almost five years. David Wyss, S&P's chief economist, expects their earnings to fall as much as 30 percent in the fourth quarter as companies take more writedowns for bad investments.

Consensus estimates compiled by Bloomberg indicate S&P 500 operating profits may rise just 1.1 percent in the current quarter.

The biggest hit to the economy from fading financial profits may come from tighter lending standards. The Federal Reserve reported last month that banks were making it harder for businesses and consumers to borrow.

Scarce credit could make things even tougher for companies such as Brunswick Corp. of Lake Forest, Illinois, maker of Bayliner boats. The firm is cutting 170 jobs as it struggles with what Chief Executive Officer Dustan McCoy suggested might be the weakest U.S. boat market since 1965.

– Bloomberg

The [Japanese] yen rebounded from a two-week low against the dollar after Moody's Investors Service said it is preparing the biggest credit-rating cuts since subprime-mortgage defaults rocked financial markets.

The yen rose versus all 16 most-traded currencies as investors retreated from carry trades and sold higher-yielding assets bought with loans from Japan. The yen also advanced as Bank of Japan Governor Toshihiko Fukui signaled interest rates may have to rise.

"There's been a broad-based retreat from risk across the board, and the yen always benefits in that environment," said Simon Derrick, chief currency strategist at Bank of New York Mellon Corp. in London. "With people worried about economic growth and subprime-mortgage losses the yen is clearly going to benefit."
– Bloomberg

How Our Ideas Will Perform Even Better in 2008
December 3, 2007

The Best Place to Buy Real Estate in Asia
December 1, 2007

A Heartland Boondoggle: The World's Most Hated Commodity
November 30, 2007

This Obscure Commodity Could Quadruple Over The Next 10 Years
November 29, 2007

The Best Precious Metals Investment You Can Make Today
November 28, 2007

Home | About DailyWealth | Premium Content | DailyWealth Archive | Contributors
DailyWealth Resources | Research Reports | Privacy Policy

Customer Service: 1-888-261-2693 – Copyright 2008 Stansberry & Associates Investment Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This e-letter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry & Associates Investment Research, LLC. 1217 Saint Paul Street, Baltimore MD 21202